BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10099074)

  • 1. Nasal effect of cetirizine and loratadine at 24 hours in patients with allergic rhinitis.
    Frossard N; Benabdesselam O; Melac M; Glasser N; Lacronique J; Pauli G
    Am J Ther; 1998 Sep; 5(5):307-11. PubMed ID: 10099074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onset of action in the nasal antihistaminic effect of cetirizine and loratadine in patients with allergic rhinitis.
    Frossard N; Lacronique J; Melac M; Benabdesselam O; Braun JJ; Glasser N; Pauli G
    Allergy; 1997 Feb; 52(2):205-9. PubMed ID: 9105526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of histamine-induced nasal obstruction by cetirizine in allergic rhinitis.
    Braunstein G; Malaquin F; Fajac I; Melac M; Frossard N
    Br J Clin Pharmacol; 1992 Apr; 33(4):445-8. PubMed ID: 1349494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
    Day JH; Briscoe M; Widlitz MD
    J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind comparison of cetirizine and loratadine in children ages 2 to 6 years with perennial allergic rhinitis.
    Sienra-Monge JJ; Gazca-Aguilar A; Del Rio-Navarro B
    Am J Ther; 1999 May; 6(3):149-55. PubMed ID: 10423657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between nasal provocation tests and skin tests in patients treated with loratadine and cetirizine.
    Persi L; Demoly P; Harris AG; Tisserand B; Michel FB; Bousquet J
    J Allergy Clin Immunol; 1999 Apr; 103(4):591-4. PubMed ID: 10200006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind study of cetirizine and loratadine versus placebo in patients with allergic rhinitis.
    Nunes C; Ladeira S
    J Investig Allergol Clin Immunol; 2000; 10(1):20-3. PubMed ID: 10780795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of ebastine, cetirizine, and loratadine in histamine cutaneous challenges.
    Gispert J; Antonijoan R; Barbanoj M; Gich I; Garcia E; Esbrí R; Luria X
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):259-64. PubMed ID: 12269645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test system.
    Day JH; Briscoe M; Rafeiro E; Chapman D; Kramer B
    Ann Allergy Asthma Immunol; 2001 Dec; 87(6):474-81. PubMed ID: 11770694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do nasal mast cells release histamine on stimulation with substance P in allergic rhinitis?
    Braunstein G; Buvry A; Lacronique J; Desjardins N; Frossard N
    Clin Exp Allergy; 1994 Oct; 24(10):922-9. PubMed ID: 7531109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study.
    Ciprandi G; Cirillo I; Vizzaccaro A; Civardi E; Barberi S; Allen M; Marseglia GL
    Int Immunopharmacol; 2005 Dec; 5(13-14):1800-8. PubMed ID: 16275616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative outdoor study of the efficacy, onset and duration of action, and safety of cetirizine, loratadine, and placebo for seasonal allergic rhinitis.
    Meltzer EO; Weiler JM; Widlitz MD
    J Allergy Clin Immunol; 1996 Feb; 97(2):617-26. PubMed ID: 8621847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology of the H1-receptor antagonists cetirizine and loratadine in children.
    Simons FE; Johnston L; Simons KJ
    Pediatr Allergy Immunol; 2000 May; 11(2):116-9. PubMed ID: 10893015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cetirizine reduces cytokines and inflammatory cells in children with perennial allergic rhinitis.
    Ciprandi G; Tosca MA; Milanese M; Ricca V
    Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):237-40. PubMed ID: 15329007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loratadine versus cetirizine: assessment of somnolence and motivation during the workday.
    Salmun LM; Gates D; Scharf M; Greiding L; Ramon F; Heithoff K
    Clin Ther; 2000 May; 22(5):573-82. PubMed ID: 10868555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expression.
    Ciprandi G; Pronzato C; Ricca V; Passalacqua G; Danzig M; Canonica GW
    Clin Exp Allergy; 1997 Oct; 27(10):1175-83. PubMed ID: 9383258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for the relief of symptoms of allergic rhinitis.
    Day JH; Briscoe MP; Clark RH; Ellis AK; Gervais P
    Ann Allergy Asthma Immunol; 1997 Aug; 79(2):163-72. PubMed ID: 9291422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of cetirizine plus pseudoephedrine versus loratadine plus pseudoephedrine for perennial allergic rhinitis.
    Chiang YC; Shyur SD; Chen TL; Huang LH; Wen TC; Lin MT; Yang HC; Liang PH; Kao YH; Wang TC
    Asian Pac J Allergy Immunol; 2006; 24(2-3):97-103. PubMed ID: 17136873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and ex vivo inhibitory effects of loratadine on histamine release in patients with allergic rhinitis.
    Miadonna A; Cottini M; Milazzo N; Tosi D; Danzig M; Tedeschi A
    Allergy; 1998 Dec; 53(12):1183-8. PubMed ID: 9930595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of soluble ICAM-1 levels in nasal secretion by H1-blockers in seasonal allergic rhinitis.
    Campbell A; Chanal I; Czarlewski W; Michel FB; Bousquet J
    Allergy; 1997 Oct; 52(10):1022-5. PubMed ID: 9360756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.